Swiss National Bank Sells 2,900 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Swiss National Bank lowered its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) by 1.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 193,500 shares of the company’s stock after selling 2,900 shares during the quarter. Swiss National Bank owned about 0.23% of Pediatrix Medical Group worth $2,875,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Eagle Bay Advisors LLC grew its stake in Pediatrix Medical Group by 122.5% in the 2nd quarter. Eagle Bay Advisors LLC now owns 1,595 shares of the company’s stock valued at $34,000 after buying an additional 878 shares during the last quarter. Royal Bank of Canada grew its stake in Pediatrix Medical Group by 97.3% in the 3rd quarter. Royal Bank of Canada now owns 2,166 shares of the company’s stock valued at $35,000 after buying an additional 1,068 shares during the last quarter. Point72 Hong Kong Ltd acquired a new position in Pediatrix Medical Group in the 3rd quarter valued at $43,000. Marshall & Sullivan Inc. WA acquired a new position in Pediatrix Medical Group in the 4th quarter valued at $43,000. Finally, Tower Research Capital LLC TRC grew its stake in Pediatrix Medical Group by 123.1% in the 3rd quarter. Tower Research Capital LLC TRC now owns 6,558 shares of the company’s stock valued at $108,000 after buying an additional 3,618 shares during the last quarter. Institutional investors own 95.99% of the company’s stock.

Insider Activity at Pediatrix Medical Group

In related news, Director Shirley A. Weis sold 17,993 shares of Pediatrix Medical Group stock in a transaction dated Thursday, May 18th. The shares were sold at an average price of $13.55, for a total transaction of $243,805.15. Following the completion of the transaction, the director now directly owns 18,675 shares of the company’s stock, valued at approximately $253,046.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts have issued reports on MD shares. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Pediatrix Medical Group from $15.50 to $14.00 in a research report on Wednesday, May 3rd. Credit Suisse Group decreased their price target on shares of Pediatrix Medical Group from $27.00 to $23.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 22nd. Mizuho decreased their price target on shares of Pediatrix Medical Group from $17.00 to $15.00 in a research report on Wednesday, May 3rd. StockNews.com started coverage on shares of Pediatrix Medical Group in a research report on Thursday, May 18th. They issued a “hold” rating on the stock. Finally, Truist Financial decreased their price target on shares of Pediatrix Medical Group from $17.00 to $15.00 in a research report on Tuesday, May 9th. Four analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $17.67.

Pediatrix Medical Group Price Performance

Shares of Pediatrix Medical Group stock opened at $13.53 on Wednesday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.44 and a current ratio of 1.44. The firm’s 50-day simple moving average is $14.27 and its 200-day simple moving average is $15.01. Pediatrix Medical Group, Inc. has a twelve month low of $12.84 and a twelve month high of $23.95. The firm has a market cap of $1.13 billion, a P/E ratio of 11.09, a price-to-earnings-growth ratio of 0.61 and a beta of 1.74.

Pediatrix Medical Group Profile

(Get Rating)

Pediatrix Medical Group, Inc engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.